Binsalamah Ziyad 13D and 13G filings for Interpace Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-08-20 3:57 pm Sale |
2020-08-18 | 13D | Interpace Biosciences, Inc. IDXG |
Binsalamah Ziyad | 0 0.000% |
-300,000 (Position Closed) |
Filing |
| 2020-07-24 09:10 am Purchase |
2020-07-21 | 13D | Interpace Biosciences, Inc. IDXG |
Binsalamah Ziyad | 300,000 7.430% |
300,000 (New Position) |
Filing |